- Home
- FRPT vs QURE Comparison
FRPT vs QURE Comparison
Compare FRPT & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRPT | QURE |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | 248 |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.1B |
| IPO Year | 2014 | 2013 |
Fundamental Metrics
Financial Performance| Metric | FRPT | QURE |
|---|---|---|
| Price | $57.72 | $23.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 12 |
| Target Price | ★ $84.25 | $68.25 |
| AVG Volume (30 Days) | 878.4K | ★ 1.9M |
| Earning Date | 11-02-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 183.87 | 29.67 |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $1,102,015,000.00 | $13,107,000.00 |
| Revenue This Year | $11.17 | $55.91 |
| Revenue Next Year | $8.54 | $356.42 |
| P/E Ratio | $44.19 | ★ N/A |
| Revenue Growth | ★ 13.01 | N/A |
| 52 Week Low | $46.45 | $8.73 |
| 52 Week High | $86.00 | $71.50 |
Technical Indicators
Market Signals| Indicator | FRPT | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 25.23 | 19.51 |
| Support Level | $51.41 | $21.91 |
| Resistance Level | $58.16 | $27.66 |
| Average True Range (ATR) | 1.81 | 2.13 |
| MACD | -0.50 | -2.26 |
| Stochastic Oscillator | 13.62 | 10.03 |
Price Performance
Historical ComparisonAbout FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (likely representing well north of 90% of sales), with cats and treats nascent contributors. Geographically, the company's home US market, where all its food is produced, accounts for nearly all of sales, with exports to Canada, the United Kingdom, and other European countries being very small contributors.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.